US Patent Issued to ADAMED PHARMA on June 3 for "Indole and benzimidazole derivatives as dual 5-HT 2A and 5-HT 6 receptor antagonists" (Polish Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,682, issued on June 3, was assigned to ADAMED PHARMA S.A. (Czosnow, Poland).

"Indole and benzimidazole derivatives as dual 5-HT 2A and 5-HT 6 receptor antagonists" was invented by Marcin Kolaczkowski (Wieliczka, Poland), Adam Bucki (Przebieczany, Poland), Joanna Sniecikowska (Wieliczka, Poland) and Monika Marcinkowska (Cracow, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to new 4-(piperazin-1-yl)-2-(trifluoromethyl)-1H-indoles and 4-(piperazin-1-yl)-2-(trifluoromethyl)-1H-benzimidazoles represented by formula (I), wherein all symbols and variables are as defined in the description. The compounds can find use in a method...